Lupus Log Switzerland

GlaxoSmithKline PLC · iOS

Lupus Log Switzerland

Explore the ad evidence, study the storefront, and build your next acquisition hypothesis.

Paid-ad activity not yet verified
Compare appsMy watchlist

01 / Creative research

Turn the unknowns into a research plan.

01

Check the acquisition promise

Read the store headline, screenshots and description. What problem is the app promising to solve?

Study the storefront ↗
02

Look for ad evidence

Explore apps with direct store-link matches. Compare their hooks and formats without assuming the same approach works here.

Browse observed advertisers ↗
03

Separate demand from paid growth

Store rankings and revenue estimates describe market context. They do not establish ad spend, conversions or ROAS.

Review the market context ↗

02 / Storefront & product

Where the click lands.

Study the product story and store experience behind the acquisition funnel.

Screenshots

Lupus Log Switzerland screenshot 1Lupus Log Switzerland screenshot 2Lupus Log Switzerland screenshot 3Lupus Log Switzerland screenshot 4Lupus Log Switzerland screenshot 5Lupus Log Switzerland screenshot 6Lupus Log Switzerland screenshot 7Lupus Log Switzerland screenshot 8

03 / Market context

The business behind the app.

Keep revenue, downloads and store rankings separate from advertising performance.

How Much Does Lupus Log Switzerland Make?

Monthly Revenue
$1.0K
Annualized estimate
$12.0K
Per Download
$1.00

Platform Performance

🍎iOS
Revenue
$1.0K
Downloads
1.0K
Rating
5.0 ★(1)

Rating Distribution

5.0
★★★★★
1 reviews
5
0%
4
0%
3
0%
2
0%
1
100%

Top Countries

🇨🇭 CH
Version History (5)▼
1.2.43/19/2026
1.2.32/3/2026
1.0.25/2/2023
1.0.14/21/2023
1.03/27/2023
Available In (1 Countries)▼
🇨🇭 Switzerland
Supported Languages (1)▼
German
App Details▼

Die Lupus Log App ist für Patient*innen mit Systemischem Lupus Erythematodes (SLE). Die App unterstützt dabei, ein interaktives Symptom-Tagebuch zu fü...

iOS App ID
6446711124
Content Rating
13+
Min OS
13.0
Size
36.7 MB
Publisher
GlaxoSmithKline PLC
Un